Screening scheme development for active TB prediction among HIV-infected patients

The objective of this study was to develop and evaluate a simple scoring scheme to screen for active tuberculosis (TB) among HIV-infected patients. Two hundred fifty-seven HIV-infected patients were enrolled in the study between April 2009 and May 2010 from Mae Sai District Hospital and Lampang Regi...

Full description

Saved in:
Bibliographic Details
Main Authors: Nanta S., Kantipong P., Pathipvanich P., Ruengorn C., Tawichasri C., Patumanond J.
Format: Article
Language:English
Published: 2014
Online Access:http://www.scopus.com/inward/record.url?eid=2-s2.0-80054914710&partnerID=40&md5=7eb062fc01321c734094a2a11d2c9b8d
http://www.ncbi.nlm.nih.gov/pubmed/22299469
http://cmuir.cmu.ac.th/handle/6653943832/3011
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English
id th-cmuir.6653943832-3011
record_format dspace
spelling th-cmuir.6653943832-30112014-08-30T02:25:39Z Screening scheme development for active TB prediction among HIV-infected patients Nanta S. Kantipong P. Pathipvanich P. Ruengorn C. Tawichasri C. Patumanond J. The objective of this study was to develop and evaluate a simple scoring scheme to screen for active tuberculosis (TB) among HIV-infected patients. Two hundred fifty-seven HIV-infected patients were enrolled in the study between April 2009 and May 2010 from Mae Sai District Hospital and Lampang Regional Hospital. Participants underwent routine evaluations to diagnose TB. Data collection included demographics, medical history, signs and symptoms and laboratory results. Of the 257 HIV-infected patients enrolled, 66 (25.7%) were diagnosed with active TB. Six variables were statistically significant predictors of active TB (p<0.05): BMI ≤19 kg/m2, cough >2 weeks, shaking chills ≥1 week, not taking antiretroviral drugs, a CD4+ cell count level ≤200 cells/μl, and had a history of TB. A risk score (ranging from 0 to 16) gave a 92.1% sensitivity of being associated with active TB. A low risk score (≤ 2.0), a moderate risk score (3.0-7.0), and a high risk score (>7.0) gave positive likelihood ratios (LHR+) of 0.04 (95%CI 0.01-0.24), 2.56 (95%CI 1.71-3.85), and 11.72 (95%CI 4.91-27.96), respectively. This screening tool may be useful to identify patients who should have further diagnostic testing for TB, but requires further validation before adoption due to the variability of predicting factors and the prevalence of TB in the target population. 2014-08-30T02:25:39Z 2014-08-30T02:25:39Z 2011 Article 1251562 http://www.scopus.com/inward/record.url?eid=2-s2.0-80054914710&partnerID=40&md5=7eb062fc01321c734094a2a11d2c9b8d http://www.ncbi.nlm.nih.gov/pubmed/22299469 http://cmuir.cmu.ac.th/handle/6653943832/3011 English
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
language English
description The objective of this study was to develop and evaluate a simple scoring scheme to screen for active tuberculosis (TB) among HIV-infected patients. Two hundred fifty-seven HIV-infected patients were enrolled in the study between April 2009 and May 2010 from Mae Sai District Hospital and Lampang Regional Hospital. Participants underwent routine evaluations to diagnose TB. Data collection included demographics, medical history, signs and symptoms and laboratory results. Of the 257 HIV-infected patients enrolled, 66 (25.7%) were diagnosed with active TB. Six variables were statistically significant predictors of active TB (p<0.05): BMI ≤19 kg/m2, cough >2 weeks, shaking chills ≥1 week, not taking antiretroviral drugs, a CD4+ cell count level ≤200 cells/μl, and had a history of TB. A risk score (ranging from 0 to 16) gave a 92.1% sensitivity of being associated with active TB. A low risk score (≤ 2.0), a moderate risk score (3.0-7.0), and a high risk score (>7.0) gave positive likelihood ratios (LHR+) of 0.04 (95%CI 0.01-0.24), 2.56 (95%CI 1.71-3.85), and 11.72 (95%CI 4.91-27.96), respectively. This screening tool may be useful to identify patients who should have further diagnostic testing for TB, but requires further validation before adoption due to the variability of predicting factors and the prevalence of TB in the target population.
format Article
author Nanta S.
Kantipong P.
Pathipvanich P.
Ruengorn C.
Tawichasri C.
Patumanond J.
spellingShingle Nanta S.
Kantipong P.
Pathipvanich P.
Ruengorn C.
Tawichasri C.
Patumanond J.
Screening scheme development for active TB prediction among HIV-infected patients
author_facet Nanta S.
Kantipong P.
Pathipvanich P.
Ruengorn C.
Tawichasri C.
Patumanond J.
author_sort Nanta S.
title Screening scheme development for active TB prediction among HIV-infected patients
title_short Screening scheme development for active TB prediction among HIV-infected patients
title_full Screening scheme development for active TB prediction among HIV-infected patients
title_fullStr Screening scheme development for active TB prediction among HIV-infected patients
title_full_unstemmed Screening scheme development for active TB prediction among HIV-infected patients
title_sort screening scheme development for active tb prediction among hiv-infected patients
publishDate 2014
url http://www.scopus.com/inward/record.url?eid=2-s2.0-80054914710&partnerID=40&md5=7eb062fc01321c734094a2a11d2c9b8d
http://www.ncbi.nlm.nih.gov/pubmed/22299469
http://cmuir.cmu.ac.th/handle/6653943832/3011
_version_ 1681419967873941504